Underwriting Considerations During the COVID-19 Crisis - Will the Rules for Clinical Trials be Relaxed?
General Liability | Apr 09, 2020| English
The latest figures on the COVID-19 pandemic make for alarming reading. At the time of writing, 1,484,811 people around the world were infected with the virus and 88,537 people have died.1 No other topic is dominating the headlines quite like the coronavirus,...Read More
Disability, Life | Mar 26, 2020| English
Some insurers have added the carcinoembryonic antigen (CEA) blood test to the laboratory screening profile for Life and Health insurance applications, and some of our U.S. clients have asked for advice on whether to adopt this test. Every test has repercussions...Read More
L/H General Industry | Mar 05, 2020| English
This article describes modeling fraudulent claims in the context of a health claims portfolio. We show why this should be an iterative process and requires a dialogue between analytics experts and claims managers.Read More